Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Bollipo

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Digestive Diseases and Sciences|May 13, 2022
Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment CohortPaul J Clark, Patricia C Valery, Simone I Strasser, et al.
Journal of the Canadian Association of Gastroenterology|May 31, 2021
COVID-19 and Canadian Gastroenterology TraineesRishad Khan, Parul Tandon, Michael A Scaffidi, et al.
The Lancet. Gastroenterology & Hepatology|March 5, 2022
The present and future of gastroenterology and hepatology: an international SWOT analysis (the GASTROSWOT project)Enrique de-Madaria, José J Mira, Irene Carrillo, et al.
BMC Gastroenterology|July 12, 2022
Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-upPaul J Clark, Patricia C Valery, James Ward, et al.
Brain, Behavior, and Immunity|January 30, 2022
Defects in NLRP6, autophagy and goblet cell homeostasis are associated with reduced duodenal CRH receptor 2 expression in patients with functional dyspepsiaJessica K Bruce, Grace L Burns, Wai Sinn Soh, et al.
Frontiers in Immunology|January 23, 2023
Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsiaGrace L Burns, Jessica K Bruce, Kyra Minahan, et al.
Antiviral Therapy|April 20, 2017
Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL studyJohn Lubel, Simone Strasser, Katherine A Stuart, et al.
Clinical and Translational Gastroenterology|September 27, 2023
TRAV26-2 T-Cell Receptor Expression Is Associated With Mucosal Lymphocyte Response to Wheat Proteins in Patients With Functional DyspepsiaGrace L Burns, Michael Potter, Andrea Mathe, et al.
Endoscopy|June 1, 2022
The Toronto Upper Gastrointestinal Cleaning Score: a prospective validation studyRishad Khan, Nikko Gimpaya, Jose I Vargas, et al.
Cancers|December 23, 2023
Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie Ngu, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Digestive Diseases and Sciences|May 13, 2022
Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment CohortPaul J Clark, Patricia C Valery, Simone I Strasser, et al.
Journal of the Canadian Association of Gastroenterology|May 31, 2021
COVID-19 and Canadian Gastroenterology TraineesRishad Khan, Parul Tandon, Michael A Scaffidi, et al.
The Lancet. Gastroenterology & Hepatology|March 5, 2022
The present and future of gastroenterology and hepatology: an international SWOT analysis (the GASTROSWOT project)Enrique de-Madaria, José J Mira, Irene Carrillo, et al.
BMC Gastroenterology|July 12, 2022
Hepatitis C treatment outcomes for Australian First Nations Peoples: equivalent SVR rate but higher rates of loss to follow-upPaul J Clark, Patricia C Valery, James Ward, et al.
Brain, Behavior, and Immunity|January 30, 2022
Defects in NLRP6, autophagy and goblet cell homeostasis are associated with reduced duodenal CRH receptor 2 expression in patients with functional dyspepsiaJessica K Bruce, Grace L Burns, Wai Sinn Soh, et al.
Frontiers in Immunology|January 23, 2023
Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsiaGrace L Burns, Jessica K Bruce, Kyra Minahan, et al.
Antiviral Therapy|April 20, 2017
Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL studyJohn Lubel, Simone Strasser, Katherine A Stuart, et al.
Clinical and Translational Gastroenterology|September 27, 2023
TRAV26-2 T-Cell Receptor Expression Is Associated With Mucosal Lymphocyte Response to Wheat Proteins in Patients With Functional DyspepsiaGrace L Burns, Michael Potter, Andrea Mathe, et al.
Endoscopy|June 1, 2022
The Toronto Upper Gastrointestinal Cleaning Score: a prospective validation studyRishad Khan, Nikko Gimpaya, Jose I Vargas, et al.
Cancers|December 23, 2023
Improved Survival Outcomes with Surgical Resection Compared to Ablative Therapy in Early-Stage HCC: A Large, Real-World, Propensity-Matched, Multi-Centre, Australian Cohort StudyJonathan Abdelmalak, Simone I Strasser, Natalie Ngu, et al.
Pageof 5